Description
The global biopharmaceutical analytical instrumentation market generated a revenue of $1,092 million in 2015 and is expected to grow at a compound annual growth rate (CAGR) of 7.2% from 2015 to 2022.
The biosimilars segment, which is expected to reach $35 billion in 2025, will strongly drive the biopharmaceutical analytical instrumentation market. Strong analytical techniques will be used in the analysis of biosimilar drugs to improve product quality.
Emerging economies’ strong penetration into the global biosimilars segment will drive the need for analyzers. Key manufacturers are expanding their capabilities in these regions to bring advanced infrastructure to these markets.
Complex biopharmaceutical processes demand advanced method solutions. A combination of sensitive instruments, smart software, and advanced methods will lead to the successful deployment of practices.
Don't have an account? Create One!
Already have an account? Login!
Connect With LinkedIn
Use your Linkedin account to login or register within our store.You're just one click away.